首页> 外文会议>American College of Veterinary Internal Medicine Forum Conference >Ursodeoxycholic Acid (Ursodiol) Significantly Alters the Gut Microbiota and Bile Acid Metabolome in Conventional Mice
【24h】

Ursodeoxycholic Acid (Ursodiol) Significantly Alters the Gut Microbiota and Bile Acid Metabolome in Conventional Mice

机译:核糖核酸(Ursodiol)在常规小鼠中显着改变肠道微生物酵母和胆汁酸代谢物

获取原文

摘要

Ursodeoxycholic acid (ursodiol) is a naturally occurring bile acid that is used to treat a variety of hepatic and gastrointestinal diseases. Ursodiol has a multitude of beneficial therapeutic effects and can modulate bile acid pools. Bile acids can alter the gut microbiota community structure through various mechanisms. In turn, the gut microbial community can modulate bile acid pools, thus highlighting the interconnectedness of the gut microbiota-bile acid-host axis. Despite these interactions, it remains unclear if and how exogenously administered ursodiol shapes the indigenous gut microbial community structure and intestinal bile acid metabolome. This study aimed to provide a comprehensive analysis of how ursodiol alters the intestinal ecosystemin conventional mice.
机译:核糖核酸(Ursodiol)是一种天然存在的胆汁酸,用于治疗各种肝胃和胃肠疾病。 Ursodiol具有多种有益的治疗效果,可以调节胆汁酸库。胆汁酸可以通过各种机制改变肠道微生物群落群落结构。反过来,肠道微生物群落可以调节胆汁酸池,从而突出肠道微生物脂蛋白酸轴的互连。尽管有这些相互作用,但仍然不清楚是否还有外源性尿素钠形状的荨麻醇形状和肠胆汁代谢。本研究旨在综合分析Ursodiol如何改变肠道生态系统常规小鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号